Head-to-head comparisons of medication uses, side effects, warnings, and more.
Addyi (flibanserin) and Vyleesi (bremelanotide) are both FDA-approved treatments for low sex drive in women who haven't gone through menopause yet, but they work differently and are used in different ways. Addyi is a serotonin receptor agonist/antagonist taken as a daily pill at bedtime, while Vyleesi is a melanocortin receptor agonist that you inject under the skin as needed, at least 45 minutes before sex. Addyi has alcohol restrictions due to the risk of low blood pressure and fainting, whereas Vyleesi does not have these alcohol limitations but can briefly raise blood pressure and lower heart rate. Common side effects of Addyi include dizziness, sleepiness, and nausea, while Vyleesi often causes nausea, flushing, and injection site reactions. Additionally, Addyi is available in a generic form, but Vyleesi is not.
Addyi (flibanserin) is used for treating women with hypoactive sexual desire disorder (HSDD), or low sex drive or desire for sex. It's approved for women who haven't gone through menopause yet. The medication helps improve sexual desire, increase satisfying sexual events, and reduce stress related to low sexual desire. It's a tablet that you take once a day at bedtime. Addyi (flibanserin) side effects include dizziness, sleepiness, and nausea. Because this medication also has a risk for low blood pressure and fainting, there are some alcohol limitations with treatment.
Vyleesi (bremelanotide) treats low sex drive that causes negative emotions in people who haven't gone through menopause yet. This medication belongs to the drug class called melanocortin receptor agonists. Vyleesi (bremelanotide) is an autoinjector that you use to inject the medication under the skin. It's injected as needed at least 45 minutes before sex. Common side effects include nausea, flushing of the skin, and injection site reactions.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.